GLP-1s (such as branded agent Ozempic) have turned the obesity medicine world upside down in the last few years. Literally billions have been spent, and demand is outpacing supply. This makes sense as nearly half of Americans are obese. What's interesting, though, is how the entire obesity treatment industry is evolving based on this buzz. With costs high and access to GLP-1s being restricted by insurance providers, companies like Form Health are taking holistic approaches to weight loss for patients, both with and without GLP-1s as part of the treatment plan. One thing is for certain - we're in the obesity medicine gold rush, and it will be interesting to see how GLP-1s change the arc of the industry now and in the future. (May 2024)